Interpretation of the “Announcement on Matters Relating to the Registration and Notification of Cosmetics (Draft for Comments)”
On March 31, 2026, the Comprehensive Department of the National Medical Products Administration (NMPA) publicly solicited comments on the Announcement on Matters Relating to the Registration and Notification of Cosmetics (Draft for Comments). This draft aims to deepen the reform of cosmetic review and approval and promote high-quality industrial development through eight optimization measures. 1. Encouraging “China First” Launches for New Products To foster a “First-Launch Economy” aligned with high-standard international trade rules: 2. Reduction and Exemption of Animal Testing Data Toxicological test reports may be exempted under specific conditions: 3. Adjusting Management of Ingredient Safety Information 4. Sharing Safety Technical Data for Products with Similar Formulas This clarifies the sharing of safety data among products under the same brand and registrant: Category Core Rules Site Change Requirements Definition of Similar Formula Applicable Entities: Multiple products (incl. toothpaste) of the same brand under one registrant. Select one representative product for